![]() |
市場調查報告書
商品編碼
1499605
關節重建市場:按固定類型、關節類型、材料、技術和最終用戶分類 - 2024-2030 年全球預測Joint Replacement Market by Fixation Type (Cemented, Cementless, Hybrid), Joint Type (Ankle Replacement, Finger or Hand Joints Replacement, Hip Replacement), Material, Procedure, End-Use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年關節重建市場規模為182.5億美元,預計2024年將達192.2億美元,2030年將達264.7億美元,複合年成長率為5.45%。
關節重建手術是用人工關節取代受損或功能障礙的關節的外科手術。關節重建手術有助於緩解嚴重關節疼痛或退化性關節疾病患者的疼痛、改善活動能力並改善生活品質。關節重建手術的主要應用是在醫療領域,特別是用於治療因各種疾病而遭受嚴重關節疼痛和喪失活動能力的患者。骨關節炎和類風濕性關節炎的盛行率不斷增加,特別是在老年人中,增加了對關節重建手術的需求,也是市場成長的基礎。人們對關節重建手術的認知不斷提高以及與手術相關的報銷政策的可用性進一步推動了市場的成長。替代治療選擇以及術後併發症和風險正在阻礙市場成長。手術技術方面不斷湧現的技術創新和義肢設計的增強以改善手術效果預計將為市場成長創造機會。此外,使用具有優異耐用性和與人體相容性的材料也有望促進市場成長。
主要市場統計 | |
---|---|
基準年[2023] | 182.5億美元 |
預測年份 [2024] | 192.2億美元 |
預測年份 [2030] | 264.7億美元 |
複合年成長率(%) | 5.45% |
區域洞察
美洲是一個不斷成長的髖關節和膝關節關節重建市場,主要是由於需要控制導致關節退化的疾病(例如置換術和肥胖症)的流行,這是一個非常發達的地區。先進的醫療置換術和高昂的醫療成本也支撐了美洲髖關節和膝關節關節重建的龐大市場。在亞太地區,由於老年人口的增加、醫療水準的提高以及經濟狀況的改善,關節重建市場正在快速成長。中國、印度和日本等國家正受益於醫療設施的改善、願意投資健康解決方案的中階的崛起以及關節重建手術的普及。歐洲是關節重建手術的新興市場,擁有先進的醫療保健系統和較高的關節重建手術認知度。支持性健康保險和報銷政策也促進了歐洲、中東和非洲市場的成長。由於醫療基礎設施的改善和政府對醫療服務的舉措,中東和非洲的關節重建市場正在成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在關節重建市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可對關節重建市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外,該分析還提供了對該行業競爭性質的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前關節重建市場地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[185 Pages Report] The Joint Replacement Market size was estimated at USD 18.25 billion in 2023 and expected to reach USD 19.22 billion in 2024, at a CAGR 5.45% to reach USD 26.47 billion by 2030.
Joint replacement is a surgical procedure in which damaged or dysfunctional joints are replaced with prosthetics. Joint replacement helps to relieve pain, improve mobility, and enhance the quality of life for individuals suffering from severe joint pain or degenerative joint diseases. The primary application of joint replacements is in the medical field, particularly in treating patients suffering from severe joint pain and immobility due to various conditions. The increased prevalence of osteoarthritis and rheumatoid arthritis, especially among the elderly population, is raising the need for joint replacement surgeries, creating a platform for market growth. Growing awareness about joint replacement surgeries and the availability of reimbursement policies associated with surgeries are further driving the market's growth. The availability of alternative treatment options and certain post-surgery complications and risks hamper the market growth. Rising innovations in surgical techniques and enhancements in prosthetic design that improve the outcomes of joint replacement surgeries are expected to create opportunities for market growth. Using materials that offer greater durability and compatibility with the human body is also expected to contribute to the market's growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 18.25 billion |
Estimated Year [2024] | USD 19.22 billion |
Forecast Year [2030] | USD 26.47 billion |
CAGR (%) | 5.45% |
Regional Insights
Americas represents a highly developing landscape for joint replacement surgeries, primarily due to an increasing need to manage the rising prevalence of conditions including osteoarthritis and obesity that contribute to joint degeneration. Advanced healthcare infrastructure and higher healthcare expenditure also support a large market for both hip and knee replacement surgeries in the Americas. The APAC region is experiencing rapid growth in the joint replacement market due to an increasing elderly population, rising healthcare standards, and improving economic conditions contribute to this growth. Countries including China, India, and Japan have benefitted from the growing accessibility to healthcare facilities and a rising middle class willing to invest in health solutions, subsequently expanding the accessibility of joint replacement surgeries. Europe is a developing market for joint replacement with advanced healthcare systems and high awareness of joint replacement procedures. Supportive health insurance and reimbursement policies also contribute to the market growth in EMEA. The Middle East and Africa have a growing joint replacement market, influenced by improving healthcare infrastructure and government initiatives towards health services.
Market Insights
The market dynamics represent an ever-changing landscape of the Joint Replacement Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Joint Replacement Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Joint Replacement Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Intellijoint Surgical Expands Market Reach with Intellijoint KNEE Approval in Japan
Intellijoint Surgical received regulatory approval in Japan for its innovative product, Intellijoint KNEE, marking a significant expansion in the global computer-assisted surgical navigation market. This technology offers orthopedic surgeons real-time, accurate measurements for surgical cutting guides during total knee replacements. It is adaptable to all implant brands, enhancing its integration into existing surgical workflows. [Published On: 2024-03-07]
FDA Approval Enhances Treatment for Early-Stage Knee Osteoarthritis
The U.S. Food and Drug Administration (FDA) approved the MISHA Knee System, an implantable device designed to alleviate symptoms of early-stage knee osteoarthritis. Specifically targeting patients experiencing persistent pain despite conventional nonsurgical interventions, such as weight loss and physical therapy, this device strategically reduces the weight-bearing load by one-third on the medial side of the knee, thereby lessening joint stress. Primarily aimed at patients not yet requiring total knee replacement, the MISHA Knee System is a transitional solution, potentially delaying the need for more invasive procedures and appealing particularly to younger, active individuals. [Published On: 2023-04-25]
Aster Medcity Introduces Robotic Technology for Knee Replacement Surgeries
Aster Medcity introduced a state-of-the-art, fully automated robot designed explicitly for high-precision knee replacement surgeries. Knee replacement surgery, typically advised for severe joint pain unresponsive to standard treatments, involves replacing the damaged joint surfaces to alleviate discomfort and improve mobility. This robotic system promises to refine this procedure by ensuring increased accuracy and potentially better patient recovery rates. [Published On: 2023-01-23]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Joint Replacement Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Joint Replacement Market, highlighting leading vendors and their innovative profiles. These include Aditi Corporation, Aesculap, Inc., Arthrex, Inc., B. Braun SE, Corin Group, DJO Global Inc., Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kyocera Corporation, Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, NuVasive Inc., Orthofix Medical Inc., Smith & Nephew PLC, Stryker Corporation, Uteshiya Medicare Private Limited, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage